Trials / Conditions / Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
4 registered clinical trials studyying Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058 | Emory University | N/A |
| Recruiting | Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous NCT06580054 | University of Michigan Rogel Cancer Center | Phase 2 |
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Tr NCT04576091 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cel NCT03565783 | M.D. Anderson Cancer Center | Phase 2 |